Cytosorbents (CTSO) Competitors $0.87 +0.02 (+2.26%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.84 -0.03 (-3.47%) As of 08/1/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTSO vs. SMTI, SKIN, BWAY, CVRX, MGRM, PTHL, CV, INGN, SGHT, and TLSIShould you be buying Cytosorbents stock or one of its competitors? The main competitors of Cytosorbents include Sanara MedTech (SMTI), Beauty Health (SKIN), Brainsway (BWAY), CVRx (CVRX), Monogram Orthopaedics (MGRM), Pheton (PTHL), CapsoVision (CV), Inogen (INGN), Sight Sciences (SGHT), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry. Cytosorbents vs. Its Competitors Sanara MedTech Beauty Health Brainsway CVRx Monogram Orthopaedics Pheton CapsoVision Inogen Sight Sciences TriSalus Life Sciences Sanara MedTech (NASDAQ:SMTI) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends. Do analysts rate SMTI or CTSO? Sanara MedTech currently has a consensus price target of $49.50, indicating a potential upside of 104.88%. Cytosorbents has a consensus price target of $5.50, indicating a potential upside of 532.77%. Given Cytosorbents' higher possible upside, analysts clearly believe Cytosorbents is more favorable than Sanara MedTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Cytosorbents 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is SMTI or CTSO more profitable? Sanara MedTech has a net margin of -12.48% compared to Cytosorbents' net margin of -41.77%. Sanara MedTech's return on equity of -29.22% beat Cytosorbents' return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-12.48% -29.22% -13.20% Cytosorbents -41.77%-105.04%-29.18% Do institutionals and insiders believe in SMTI or CTSO? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 32.9% of Cytosorbents shares are held by institutional investors. 42.6% of Sanara MedTech shares are held by insiders. Comparatively, 7.3% of Cytosorbents shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, SMTI or CTSO? Sanara MedTech has higher revenue and earnings than Cytosorbents. Sanara MedTech is trading at a lower price-to-earnings ratio than Cytosorbents, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M2.48-$9.66M-$1.34-18.03Cytosorbents$35.33M1.54-$20.72M-$0.28-3.10 Does the media favor SMTI or CTSO? In the previous week, Cytosorbents had 3 more articles in the media than Sanara MedTech. MarketBeat recorded 3 mentions for Cytosorbents and 0 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 0.00 equaled Cytosorbents'average media sentiment score. Company Overall Sentiment Sanara MedTech Neutral Cytosorbents Neutral Which has more risk and volatility, SMTI or CTSO? Sanara MedTech has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Cytosorbents has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. SummarySanara MedTech beats Cytosorbents on 10 of the 15 factors compared between the two stocks. Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTSO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTSO vs. The Competition Export to ExcelMetricCytosorbentsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$54.42M$10.40B$5.49B$9.52BDividend YieldN/A1.99%4.73%4.09%P/E Ratio-3.1018.4228.7823.81Price / Sales1.5429.01372.2066.04Price / CashN/A22.3135.4557.96Price / Book4.353.478.275.54Net Income-$20.72M$234.77M$3.25B$259.28M7 Day Performance-7.88%-4.82%-3.70%-4.64%1 Month Performance-13.08%1.80%4.34%4.41%1 Year Performance-27.57%-12.51%25.90%17.95% Cytosorbents Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTSOCytosorbents1.1869 of 5 stars$0.87+2.3%$5.50+532.8%-24.4%$54.42M$35.33M-3.10220News CoverageUpcoming EarningsGap UpHigh Trading VolumeSMTISanara MedTech1.599 of 5 stars$25.03-2.0%$49.50+97.8%-19.4%$226.91M$86.67M-18.6860SKINBeauty Health1.4975 of 5 stars$1.76-1.7%$1.13-36.1%-10.0%$225.53M$334.30M-4.291,030Trending NewsUpcoming EarningsAnalyst ForecastBWAYBrainsway3.2569 of 5 stars$12.00+2.3%$14.25+18.8%+64.6%$221.67M$41.02M60.00120News CoverageUpcoming EarningsCVRXCVRx2.7029 of 5 stars$8.43+1.1%$14.50+72.0%-8.9%$217.45M$51.29M-3.87160Upcoming EarningsGap DownMGRMMonogram Orthopaedics1.3206 of 5 stars$5.69+0.2%$5.40-5.1%+128.4%$202.71M$370K-12.6428News CoveragePositive NewsPTHLPhetonN/A$30.96+6.2%N/AN/A$191.87M$450K0.0011News CoveragePositive NewsCVCapsoVisionN/A$4.35+8.8%$5.50+26.4%N/A$185.38MN/A0.0090News CoveragePositive NewsAnalyst RevisionINGNInogen4.2122 of 5 stars$6.79-0.1%$11.00+62.0%-31.8%$182.83M$335.70M-5.901,030Upcoming EarningsSGHTSight Sciences2.0932 of 5 stars$3.54+1.4%$3.93+11.1%-55.9%$180.42M$79.87M-3.61210TLSITriSalus Life Sciences2.2113 of 5 stars$4.55-0.2%$10.75+136.3%-27.9%$172.55M$29.43M-4.06106 Related Companies and Tools Related Companies SMTI Competitors SKIN Competitors BWAY Competitors CVRX Competitors MGRM Competitors PTHL Competitors CV Competitors INGN Competitors SGHT Competitors TLSI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTSO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytosorbents With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.